Nekton Capital Ltd. Bio N Tech Se Transaction History
Nekton Capital Ltd.
- $22.1 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
356Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.02 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$555 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$536 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$222 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...